TY - JOUR
T1 - Identification of genes potentially involved in disease transformtaion of CML
AU - Janssen, J. J.W.M.
AU - Klaver, S. M.
AU - Waisfisz, Q.
AU - Pasterkamp, G.
AU - de Kleijn, D. P.V.
AU - Schuurhuis, G. J.
AU - Ossenkoppele, G. J.
PY - 2005/1/1
Y1 - 2005/1/1
N2 - In patients with chronic myeloid leukemia (CML) who do not reach a (near) complete cytogenetic response, the disease progresses over several years from an indolent, chronic phase into a rapidly fatal blast crisis. Events that are responsible for this transformation process are largely unknown. To identify changes in gene expression that occurred during the course of the disease, we performed cDNA subtraction on sequentially stored peripheral blood mononuclear cell pellets, collected throughout the course of disease of a single CML patient. In total, 32 differentially expressed sequences were identified, of which 27 corresponded to known genes. On quantitative PCR, eight of these genes, YWHAZ, GAS2, IL8, IL6, PBEF1, CCL4, SAT and MMRN, showed comparable differential expression in additional CML patient samples. This set of genes can be considered as a starting point for further research on causes of disease transformation in CML and may lead to new targets in the treatment of resistant CML.
AB - In patients with chronic myeloid leukemia (CML) who do not reach a (near) complete cytogenetic response, the disease progresses over several years from an indolent, chronic phase into a rapidly fatal blast crisis. Events that are responsible for this transformation process are largely unknown. To identify changes in gene expression that occurred during the course of the disease, we performed cDNA subtraction on sequentially stored peripheral blood mononuclear cell pellets, collected throughout the course of disease of a single CML patient. In total, 32 differentially expressed sequences were identified, of which 27 corresponded to known genes. On quantitative PCR, eight of these genes, YWHAZ, GAS2, IL8, IL6, PBEF1, CCL4, SAT and MMRN, showed comparable differential expression in additional CML patient samples. This set of genes can be considered as a starting point for further research on causes of disease transformation in CML and may lead to new targets in the treatment of resistant CML.
KW - CML
KW - Subtractive hybridisation
KW - Transformation
UR - http://www.scopus.com/inward/record.url?scp=20844440739&partnerID=8YFLogxK
U2 - 10.1038/sj.leu.2403735
DO - 10.1038/sj.leu.2403735
M3 - Article
C2 - 15815727
AN - SCOPUS:20844440739
SN - 0887-6924
VL - 19
SP - 998
EP - 1004
JO - Leukemia
JF - Leukemia
IS - 6
ER -